Bullish option flow detected in Crispr Therapeutics (CRSP) with 12,553 calls trading, 3x expected, and implied vol increasing over 10 points to 77.01%. 11/14 weekly 52 calls and 11/14 weekly 53 calls are the most active options, with total volume in those strikes near 4,800 contracts. The Put/Call Ratio is 0.10. Earnings are expected on February 18th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Cathie Wood Sells Tesla (TSLA) and SoFi Stocks, Makes a $34M Bet on This USDC Giant
- Crispr Therapeutics price target lowered to $77 from $87 at Citi
- Promising Outlook for Crispr Therapeutics AG: Buy Rating Backed by Strong Product Launches and Strategic Developments
- CRISPR Therapeutics Reports Q3 2025 Financial Results
- FDA appoints Richard Pazdur as Director of CDER